What is Roth Capital’s Estimate for TSE:TRU FY2025 Earnings?

Trulieve Cannabis Corp. (TSE:TRU) – Equities research analysts at Roth Capital issued their FY2025 earnings per share (EPS) estimates for shares of Trulieve Cannabis in a note issued to investors on Monday, March 3rd. Roth Capital analyst S. Fortune anticipates that the company will post earnings per share of ($0.48) for the year.

Several other research analysts have also weighed in on TRU. Atb Cap Markets raised Trulieve Cannabis from a “hold” rating to a “strong-buy” rating in a research report on Monday, December 9th. Craig Hallum raised Trulieve Cannabis to a “strong-buy” rating in a research report on Wednesday, February 26th.

Trulieve Cannabis Price Performance

Insider Activity

In other news, Senior Officer Wes Getman bought 9,500 shares of Trulieve Cannabis stock in a transaction dated Friday, December 13th. The stock was bought at an average cost of C$7.02 per share, for a total transaction of C$66,702.35.

About Trulieve Cannabis

TransUnion provides risk and information solutions. The company operates in three segments: U.S. Markets, International, and Consumer Interactive. The U.S. Markets segment provides consumer reports, actionable insights, and analytics to businesses. These businesses use its services to acquire new customers; assess consumer ability to pay for services; identify cross-selling opportunities; measure and manage debt portfolio risk; collect debt; verify consumer identities; and mitigate fraud risk.